Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Ling, Zongxin ^a   Liu, Xia ^a,b   Jia, Xiaoyun ^c   Cheng, Yiwen ^a   Luo, Yueqiu ^a   Yuan, Li ^a   Wang, Yuezhu ^d   Zhao, Chunna ^c   Guo, Shu ^c   Li, Lanjuan ^a   Xu, Xiwei ^c   Xiang, Charlie ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; RNA 16S;

CASE CONTROL STUDY; COMPARATIVE STUDY; DIARRHEA; DNA SEQUENCE; FECES; GENETICS; HUMAN; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; PSEUDOMEMBRANOUS COLITIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION;

BACTERIAL TOXINS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; INTESTINES; MICROBIOTA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84936946364     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07485     Document Type: Article

References (55)

1. Underwood, S. et al. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol 191, 7296-7305 (2009).
2. Khanna, S., Pardi, D. S., Aronson, S. L., Kammer, P. P. & Baddour, L. M. Outcomes in community-acquired Clostridium difficile infection. Aliment Pharmacol Ther 35, 613-618 (2012).
3. Khanna, S. et al. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis 56, 1401-1406 (2013).
4. Enoch, D. A., Butler, M. J., Pai, S., Aliyu, S. H. & Karas, J. A. Clostridium difficile in children: colonisation and disease. J Infect 63, 105-113 (2011).
5. Rousseau, C. et al. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 55, 1209-1215 (2012).
6. Warny, M. et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366, 1079-1084 (2005).
7. He, M. et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45, 109-113 (2013).
8. Zilberberg, M. D., Tillotson, G. S. & McDonald, C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 16, 604-609 (2010).
9. Adamu, B. O. & Lawley, T. D. Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection. Curr Opin Microbiol 16, 596-601 (2013).
10. Lawley, T. D. & Walker, A. W. Intestinal colonization resistance. Immunology 138, 1-11 (2013).
11. Britton, R. A. & Young, V. B. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol 20, 313-319 (2012).
12. Chang, J. Y. et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 197, 435-438 (2008).
13. Antharam, V. C. et al. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol 51, 2884-2892 (2013).
14. Rousseau, C. et al. Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition. J Clin Microbiol 49, 858-865 (2011).
15. Manges, A. R. et al. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis 202, 1877-1884 (2010).
16. van Nood, E. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368, 407-415 (2013).
17. Khoruts, A., Dicksved, J., Jansson, J. K. & Sadowsky, M. J. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44, 354-360 (2010).
18. Brandt, L. J. et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107, 1079-1087 (2012).
19. Cammarota, G., Ianiro, G. & Gasbarrini, A. Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection: A Systematic Review. J Clin Gastroenterol 48, 693-702 (2014).
20. von Eichel-Streiber, C., Boquet, P., Sauerborn, M. & Thelestam, M. Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTPbinding proteins. Trends Microbiol 4, 375-382 (1996).
21. Lyras, D. et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458, 1176-1179 (2009).
22. Kuehne, S. A. et al. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467, 711-713 (2010).
23. Kuehne, S. A. et al. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis 209, 83-86 (2014).
24. Goldenberg, S. D. & French, G. L. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect 62, 355-362 (2011).
25. McEllistrem, M. C., Carman, R. J., Gerding, D. N., Genheimer, C. W. & Zheng, L. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 40, 265-272 (2005).
26. Alfa, M. J. et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 38, 2706-2714 (2000).
27. Lemee, L. et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 42, 5710-5714 (2004).
28. Rea, M. C. et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol 50, 867-875 (2012).
29. Zoetendal, E. G., Rajilic-Stojanovic, M. & de Vos, W. M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615 (2008).
30. Keesing, F. et al. Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature 468, 647-652 (2010).
31. Penders, J. et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56, 661-667 (2007).
32. Shahinas, D. et al. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio 3, e00338-12 (2012).
33. Pop, M. et al. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol 15, R76 (2014).
34. Ling, Z. et al. Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates. BMC Genomics 14, 390 (2013).
35. Mariat, D. et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9, 123 (2009).
36. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006).
37. Bishara, J. et al. Obesity as a risk factor for Clostridium difficile infection. Clin Infect Dis 57, 489-493 (2013).
38. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118 (2005).
39. Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4, 1829 (2013).
40. Roberfroid, M. et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 104 Suppl 2, S1-63 (2010).
41. Million, M., Lagier, J. C., Yahav, D. & Paul, M. Gut bacterial microbiota and obesity. Clin Microbiol Infect 19, 305-313 (2013).
42. de La Serre, C. B. et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gutmicrobiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299, G440-448 (2010).
43. Jenq, R. R. et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 209, 903-911 (2012).
44. Schwiertz, A. et al.Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18, 190-195 (2010).
45. Wong, J. M., de Souza, R., Kendall, C. W., Emam, A. & Jenkins, D. J. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40, 235-243 (2006).
46. Duncan, S. H., Louis, P. & Flint, H. J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 70, 5810-5817 (2004).
47. Costa, M. C. et al. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene. PLoS One 7, e41484 (2012).
48. Karlsson, S., Lindberg, A., Norin, E., Burman, L. G. & Akerlund, T. Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and downregulated by cysteine in Clostridium difficile. Infect Immun 68, 5881-5888 (2000).
49. Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731-16736 (2008).
50. Tvede, M. & Rask-Madsen, J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1, 1156-1160 (1989).
51. Theriot, C. M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5, 3114 (2014).
52. Tanaka, S. et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol 56, 80-87 (2009).
53. Biagi, E. et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5, e10667 (2010).
54. Ling, Z. et al. Altered fecal microbiota composition associated with food allergy in infants. Appl Environ Microbiol 80, 2546-2554 (2014).
55. Segata, N. et al.Metagenomic biomarker discovery and explanation. Genome Biol 12, R60 (2011).